Analystreport

VistaGen Therapeutics, Inc. (NASDAQ: VTGN) had its price target raised by analysts at Maxim Group from $3.00 to $5.00.

VistaGen Therapeutics, Inc.  (VTGN) 
Last vistagen therapeutics, inc. earnings: 2/13 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.vistagen.com